Browse by UCL people
Group by: Type | Date
Number of items: 13.
Article
Arasanz, H;
Gato-Canas, M;
Zuazo, M;
Ibanez-Vea, M;
Breckpot, K;
Kochan, G;
Escors, D;
(2017)
PD1 signal transduction pathways in T cells.
Oncotarget
, 8
(31)
pp. 51936-51945.
10.18632/oncotarget.17232.
|
 |
|
Arce, F;
Breckpot, K;
Collins, M;
Escors, D;
(2011)
Targeting lentiviral vectors for cancer immunotherapy.
Curr Cancer Ther Rev
, 7
(4)
pp. 248-260.
10.2174/157339411797642605.
|
|
Broos, K;
Keyaerts, M;
Lecocq, Q;
Renmans, D;
Nguyen, T;
Escors, D;
Liston, A;
... Devoogdt, N; + view all
(2017)
Non-invasive assessment of murine PD-L1 levels in syngeneic tumor models by nuclear imaging with nanobody tracers.
Oncotarget
, 8
pp. 41932-41946.
10.18632/oncotarget.16708.
|
|
|
Gato-Canas, M;
Zuazo, M;
Arasanz, H;
Ibanez-Vea, M;
Lorenzo, L;
Fernandez-Hinojal, G;
Vera, R;
... Escors, D; + view all
(2017)
PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity.
Cell Reports
, 20
(8)
pp. 1818-1829.
10.1016/j.celrep.2017.07.075.
|
|
|
Hotblack, A;
Seshadri, S;
Zhang, L;
Hamrang-Yousefi, S;
Chakraverty, R;
Escors, D;
Bennett, CL;
(2016)
Dendritic Cells Cross-Present Immunogenic Lentivector-Encoded Antigen from Transduced Cells to Prime Functional T Cell Immunity.
Molecular Therapy
, 25
(2)
pp. 504-511.
10.1016/j.ymthe.2016.11.001.
|
|
Karwacz, K;
Bricogne, C;
MacDonald, D;
Arce, F;
Bennett, CL;
Collins, M;
Escors, D;
(2011)
PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8(+) T cells.
EMBO Molecular Medicine
, 3
(10)
581 - 592.
10.1002/emmm.201100165.
|
|
|
Lanna, A;
Gomes, DC;
Muller-Durovic, B;
McDonnell, T;
Escors, D;
Gilroy, DW;
Lee, JH;
... Akbar, AN; + view all
(2017)
A sestrin-dependent Erk-Jnk-p38 MAPK activation complex inhibits immunity during aging.
Nature Immunology
, 18
(3)
pp. 354-363.
10.1038/ni.3665.
|
|
|
Lanna, A;
Henson, SM;
Escors, D;
Akbar, AN;
(2014)
The kinase p38 activated by the metabolic regulator AMPK and scaffold TAB1 drives the senescence of human T cells.
Nature Immunology
, 15
pp. 965-972.
10.1038/ni.2981.
|
|
|
Martín-Sánchez, E;
Mendaza, S;
Ulazia-Garmendia, A;
Monreal-Santesteban, I;
Blanco-Luquin, I;
Córdoba, A;
Vicente-García, F;
... Guerrero-Setas, D; + view all
(2017)
CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer.
Oncotarget
, 8
(9)
pp. 15789-15801.
10.18632/oncotarget.15004.
|
|
Otano, I;
Escors, D;
Schurich, A;
Singh, H;
Robertson, F;
Davidson, BR;
Fusai, G;
... Maini, MK; + view all
(2018)
Molecular Recalibration of PD-1+ Antigen-Specific T Cells from Blood and Liver.
Molecular Therapy
10.1016/j.ymthe.2018.08.013.
|
|
|
Ritter, LM;
Macdonald, DC;
Ritter, G;
Escors, D;
Chiara, F;
Cariboni, A;
Schorge, S;
... Collins, M; + view all
(2016)
Lentiviral expression of GAD6(7) and CCK promoter-driven opsins to target interneurons in vitro and in vivo.
Journal of Gene Medicine
, 18
(1-3)
pp. 27-37.
10.1002/jgm.2873.
|
|
|
Sanber, KS;
Knight, SB;
Stephen, SL;
Bailey, R;
Escors, D;
Minshull, J;
Santilli, G;
... Takeuchi, Y; + view all
(2015)
Construction of stable packaging cell lines for clinical lentiviral vector production.
Scientific Reports
, 5
, Article 9021. 10.1038/srep09021.
|
|
Thesis
|
Liechtenstein, TM;
(2015)
Lentivector-based cancer immunotherapy silencing PD-L1 and modulating cytokine priming; development of ex vivo myeloid-derived suppressor cells to assess therapeutic efficacy.
Doctoral thesis , UCL (University College London).
|
